The treatment was approved by China’s National Medical Products Administration (NMPA) and is China's first, and the world’s second, approved IGF-1R antibody drug.

Growth hormone injections deliver a synthetic growth hormone to the body to treat hormone deficiencies and other health ...

Innovent Biologics’ Sycume receives China NMPA approval for treatment of thyroid eye disease: San Francisco Monday, March 17, 2025, 16:00 Hrs [IST] Innovent Biologics, Inc, a wo ...

Moors & Cabot Inc. boosted its stake in shares of iShares Global Infrastructure ETF (NASDAQ:IGF – Free Report) by 12.9% during the 4th quarter, according to its most recent Form 13F filing with the ...

An announcement from Innovent Biologics ( ($HK:1801) ) is now available. Innovent Biologics has announced the approval of SYCUME®, China’s first ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and ...

Researchers from the University of Wisconsin-Madison and the University of Florida have discovered a treatment for placentas ...

Lirum Therapeutics Inc. has presented data regarding their insulin-like growth factor receptor (IGF-1R) antagonist LX-101, which couples an IGF-1 variant to a cytotoxic methotrexate payload. The ...

RRB ALP CBT 1 Result 2025 Announced: The RRB has announced that the CBT 2 exam will be conducted on March 19 and 20 this year. Prashant Tamta Updated : Feb 26, 2025, 06:25 PM IST RRB ALP CBT 1 Result ...

Now confirmed as a fully fledged driver in a championship-contending car, Liam Lawson acknowledges that it’s his job to work with Max Verstappen, not against him In his first official outing in ...